Prescription drug · ANDA
Metoprolol Succinate NDC 61919-334
Metoprolol succinate 100 mg/1 · Tablet, Extended release · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 61919-334-30 | 61919033430 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-334-30)Marketed from Jan 19, 2021 | |
| 61919-334-90 | 61919033490 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (61919-334-90)Marketed from Jan 19, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol Succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 100 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Direct_Rx
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078889
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 61919-334_0e884df8-756d-2374-e063-6394a90ab34aSPL ID 0e884df8-756d-2374-e063-6394a90ab34aSPL set ID 90a69a79-5517-0ccf-e053-2995a90a441fRxCUI 866412, 866924UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N461919033430followed by a unit qualifier and the quantityPackage 61919-0334-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris. Myocardial Infarction Metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol tartrate. Oral metoprolol tartrate therapy can be initiated after intravenous metoprolol tartrate therapy, or alternatively, oral treatment can begin within 3 t…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 078889
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | Bryant Ranch Prepack | 71335-3134 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | REMEDYREPACK INC. | 70518-4456 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-7825 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | PD-Rx Pharmaceuticals, Inc. | 43063-841 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-2080 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | AvPAK | 50268-542 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | AvPAK | 50268-543 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | Quallent Pharmaceuticals Health LLC | 82009-115 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | Quallent Pharmaceuticals Health LLC | 82009-116 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | Major Pharmaceuticals | 0904-6324 |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | Cardinal Health 107, LLC | 55154-4347 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Proficient Rx LP | 63187-768 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-119 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | BluePoint Laboratories | 68001-120 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | Dr. Reddy's Laboratories Limited | 55111-468 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | Dr. Reddy's Laboratories Limited | 55111-469 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-7069 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-7070 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | Northstar Rx LLC | 72603-144 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | Northstar Rx LLC | 72603-145 |
Showing 20 of 28.